(Q39020665)

8 September 2017

title

Fixed-dose pegfilgrastim is safe and allows neutrophil recovery in patients with non-Hodgkin's lymphoma (English)

1 reference

8 September 2017

George S

1

1 reference

8 September 2017

Yunus F

2

1 reference

8 September 2017

Case D

3

1 reference

8 September 2017

Yang BB

4

1 reference

8 September 2017

Hackett J

5

1 reference

8 September 2017

Shogan JE

6

1 reference

8 September 2017

Meza LA

7

1 reference

8 September 2017

Neumann TA

8

1 reference

8 September 2017

Liang BC

9

1 reference

8 September 2017

publication date

1 October 2003

1 reference

8 September 2017

1 reference

8 September 2017

volume

44

1 reference

8 September 2017

issue

10

1 reference

8 September 2017

page(s)

1691-1696

1 reference

Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000063462

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000063462

THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000063462

Delivery of full dose CHOP chemotherapy to elderly patients with aggressive non-Hodgkin's lymphoma without G-CSF support

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000063462

The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000063462

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000063462

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000063462

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000063462

A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819031000063462

10.1080/1042819031000063462

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference